These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
189 related items for PubMed ID: 27188986
1. Neurofilament light chain in FTD is elevated not only in cerebrospinal fluid, but also in serum. Wilke C, Preische O, Deuschle C, Roeben B, Apel A, Barro C, Maia L, Maetzler W, Kuhle J, Synofzik M. J Neurol Neurosurg Psychiatry; 2016 Nov; 87(11):1270-1272. PubMed ID: 27188986 [No Abstract] [Full Text] [Related]
2. Cerebrospinal fluid and blood neurofilament light chain levels in amyotrophic lateral sclerosis and frontotemporal degeneration: A meta-analysis. Verde F, Licaj S, Soranna D, Ticozzi N, Silani V, Zambon A. Eur J Neurol; 2024 Sep; 31(9):e16371. PubMed ID: 38937912 [Abstract] [Full Text] [Related]
3. Correlations between serum and CSF pNfH levels in ALS, FTD and controls: a comparison of three analytical approaches. Wilke C, Pujol-Calderón F, Barro C, Stransky E, Blennow K, Michalak Z, Deuschle C, Jeromin A, Zetterberg H, Schüle R, Höglund K, Kuhle J, Synofzik M. Clin Chem Lab Med; 2019 Sep 25; 57(10):1556-1564. PubMed ID: 31251725 [Abstract] [Full Text] [Related]
4. Neurofilament levels as biomarkers in asymptomatic and symptomatic familial amyotrophic lateral sclerosis. Weydt P, Oeckl P, Huss A, Müller K, Volk AE, Kuhle J, Knehr A, Andersen PM, Prudlo J, Steinacker P, Weishaupt JH, Ludolph AC, Otto M. Ann Neurol; 2016 Jan 25; 79(1):152-8. PubMed ID: 26528863 [Abstract] [Full Text] [Related]
5. Monoaminergic and Kynurenergic Characterization of Frontotemporal Dementia and Amyotrophic Lateral Sclerosis in Cerebrospinal Fluid and Serum. Janssens J, Vermeiren Y, van Faassen M, van der Ley C, Kema IP, De Deyn PP. Neurochem Res; 2020 May 25; 45(5):1191-1201. PubMed ID: 32130630 [Abstract] [Full Text] [Related]
6. Diagnostic and Prognostic Biomarkers in Amyotrophic Lateral Sclerosis: Neurofilament Light Chain Levels in Definite Subtypes of Disease. Gaiani A, Martinelli I, Bello L, Querin G, Puthenparampil M, Ruggero S, Toffanin E, Cagnin A, Briani C, Pegoraro E, Sorarù G. JAMA Neurol; 2017 May 01; 74(5):525-532. PubMed ID: 28264096 [Abstract] [Full Text] [Related]
7. CSF sAPPβ, YKL-40, and NfL along the ALS-FTD spectrum. Illán-Gala I, Alcolea D, Montal V, Dols-Icardo O, Muñoz L, de Luna N, Turón-Sans J, Cortés-Vicente E, Sánchez-Saudinós MB, Subirana A, Sala I, Blesa R, Clarimón J, Fortea J, Rojas-García R, Lleó A. Neurology; 2018 Oct 23; 91(17):e1619-e1628. PubMed ID: 30291183 [Abstract] [Full Text] [Related]
16. TDP-43 as a potential biomarker for amyotrophic lateral sclerosis: a systematic review and meta-analysis. Majumder V, Gregory JM, Barria MA, Green A, Pal S. BMC Neurol; 2018 Jun 28; 18(1):90. PubMed ID: 29954341 [Abstract] [Full Text] [Related]